TY - JOUR
T1 - Effect of O6-alkylguanine-DNA alkyltransferase on the frequency and spectrum of mutations induced by N-methyl-N′-nitro-N-nitrosoguanidine in the HPRT gene of diploid human fibroblasts
AU - Lukash, Lubov L.
AU - Boldt, Janet
AU - Pegg, Anthony E.
AU - Eileen Dolan, M.
AU - Maher, Veronica M.
AU - Justin McCormick, J.
N1 - Funding Information:
We thank our colleague, Ruey-Hwa Chen, for helpful advice on the PCR amplification and sequencing of the cDNAs. The excellent technical assistance of Clarissa Stropp, Andy Mendians and Mark Tway is gratefully acknowledged. We thank Ms. Connie Williams for typing the manuscript. This research was supported in part by DHHS Grant CA21253 (V.M.M.) and CA18137 (A.E.P.) and CA47228 (M.E.D.) from the National Cancer Institute, and by a fellowship from the Deutsche Forschungsgemeinschaft of the German Federal Republic to J.B.
PY - 1991
Y1 - 1991
N2 - N-Methyl-N′-nitro-N-nitrosoguanidine (MNNG) reacts with 12 nucleophilic sites in DNA to induce a variety of lesions, but O6-methylguanine (O6-MeG) and O4-methylthymine are the most effective premutagenic lesions produced, mispairing with thymine and guanine, respectively. O6-MeG is repaired by O6-alkylguanine-DNA alkyltransferase (AGT), which removes the methyl group from the O6 position and transfers it to itself, rendering the transferase inactive. When diploid human fibroblasts were exposed to 25 μM, O6-benzylguanine (O6-BzG) in the medium for 3 h, their level of AGT activity was dramatically reduced, to a level of at most 1.6% of the control. Populations of cells pretreated with this level of O6-BzG for 2 h or not pretreated, were exposed to MNNG at a concentration of 2, 4 or 6 μM in the presence or absence of O6-BzG and assayed for survival of colony-forming ability and the frequency of 6-thioguanine-resistant cells (mutations induced in the HPRT gene). O6-BzG (25 μM) was also present in the appropriate half of the cells during the 24 h immediately follwing exposure to MNNG. This 27-h exposure to O6-BzG alone had no cytotoxic or mutagenic effect on the cells but significantly increased the cytotoxicity and mutagenecity of MNNG, increasing the mutant frequency to that found previously in human cells constitutively devoid of AGT activity. At doses of 2 μM and 4 μM MNNG, the mutant frequency observed with the AGT-depleted cells was 120 × 10-6 and 240 × 10-6, respectively; in the cells with abundant AGT activity, these values were 10 × 10-6 and 20 × 10-6, respectively. DNA-sequence analysis of the coding region of the HPRT gene in 36 independent mutants obtained from MNNG-treated AGT-depleted populations and 36 from the control populations showed that even though AGT repair lowered the frequency of mutants by more than 90%, it did not affect the kinds of mutations induced by MNNG nor the strand distribution of the premutagenic guanine lesions. In mutants from the AGT-depleted cells, there were 26 base substitutions and 13 putative splice site mutations; in the control, there were 25 base substitutions and 11 splice site mutations. All but two substitutions involved G · C with 92% being G · C → A · T. In both sets, $ ̃73% of the premutagenic lesions were located in the nontranscribed strand. Many 'hot spots' were seen, and there was evidence that AGT repaired more lesions from the 5′ half of the gene than from the 3′ half.
AB - N-Methyl-N′-nitro-N-nitrosoguanidine (MNNG) reacts with 12 nucleophilic sites in DNA to induce a variety of lesions, but O6-methylguanine (O6-MeG) and O4-methylthymine are the most effective premutagenic lesions produced, mispairing with thymine and guanine, respectively. O6-MeG is repaired by O6-alkylguanine-DNA alkyltransferase (AGT), which removes the methyl group from the O6 position and transfers it to itself, rendering the transferase inactive. When diploid human fibroblasts were exposed to 25 μM, O6-benzylguanine (O6-BzG) in the medium for 3 h, their level of AGT activity was dramatically reduced, to a level of at most 1.6% of the control. Populations of cells pretreated with this level of O6-BzG for 2 h or not pretreated, were exposed to MNNG at a concentration of 2, 4 or 6 μM in the presence or absence of O6-BzG and assayed for survival of colony-forming ability and the frequency of 6-thioguanine-resistant cells (mutations induced in the HPRT gene). O6-BzG (25 μM) was also present in the appropriate half of the cells during the 24 h immediately follwing exposure to MNNG. This 27-h exposure to O6-BzG alone had no cytotoxic or mutagenic effect on the cells but significantly increased the cytotoxicity and mutagenecity of MNNG, increasing the mutant frequency to that found previously in human cells constitutively devoid of AGT activity. At doses of 2 μM and 4 μM MNNG, the mutant frequency observed with the AGT-depleted cells was 120 × 10-6 and 240 × 10-6, respectively; in the cells with abundant AGT activity, these values were 10 × 10-6 and 20 × 10-6, respectively. DNA-sequence analysis of the coding region of the HPRT gene in 36 independent mutants obtained from MNNG-treated AGT-depleted populations and 36 from the control populations showed that even though AGT repair lowered the frequency of mutants by more than 90%, it did not affect the kinds of mutations induced by MNNG nor the strand distribution of the premutagenic guanine lesions. In mutants from the AGT-depleted cells, there were 26 base substitutions and 13 putative splice site mutations; in the control, there were 25 base substitutions and 11 splice site mutations. All but two substitutions involved G · C with 92% being G · C → A · T. In both sets, $ ̃73% of the premutagenic lesions were located in the nontranscribed strand. Many 'hot spots' were seen, and there was evidence that AGT repaired more lesions from the 5′ half of the gene than from the 3′ half.
UR - http://www.scopus.com/inward/record.url?scp=0025744481&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0025744481&partnerID=8YFLogxK
U2 - 10.1016/0027-5107(91)90196-U
DO - 10.1016/0027-5107(91)90196-U
M3 - Article
C2 - 1944354
AN - SCOPUS:0025744481
SN - 0027-5107
VL - 250
SP - 397
EP - 409
JO - Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis
JF - Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis
IS - 1-2
ER -